BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

334 related articles for article (PubMed ID: 15080312)

  • 21. Relationship of donor HLA antibody strength to the development of transfusion-related acute lung injury.
    Hashimoto S; Nakajima F; Kamada H; Kawamura K; Satake M; Tadokoro K; Okazaki H
    Transfusion; 2010 Dec; 50(12):2582-91. PubMed ID: 20667042
    [TBL] [Abstract][Full Text] [Related]  

  • 22. How much residual plasma may cause TRALI?
    Win N; Chapman CE; Bowles KM; Green A; Bradley S; Edmondson D; Wallis JP
    Transfus Med; 2008 Oct; 18(5):276-80. PubMed ID: 18937733
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Transfusion-related acute lung injury and leucocyte-reacting antibodies.
    Zupanska B; Uhrynowska M; Michur H; Maslanka K; Zajko M
    Vox Sang; 2007 Jul; 93(1):70-7. PubMed ID: 17547568
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Transfusion-related acute lung injury surveillance (2003-2005) and the potential impact of the selective use of plasma from male donors in the American Red Cross.
    Eder AF; Herron R; Strupp A; Dy B; Notari EP; Chambers LA; Dodd RY; Benjamin RJ
    Transfusion; 2007 Apr; 47(4):599-607. PubMed ID: 17381617
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Diagnosis of transfusion-related acute lung injury: TRALI or not TRALI?
    Fontaine MJ; Malone J; Mullins FM; Grumet FC
    Ann Clin Lab Sci; 2006; 36(1):53-8. PubMed ID: 16501237
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Transfusion-related acute lung injury and pulmonary edema in critically ill patients: a retrospective study.
    Rana R; Fernández-Pérez ER; Khan SA; Rana S; Winters JL; Lesnick TG; Moore SB; Gajic O
    Transfusion; 2006 Sep; 46(9):1478-83. PubMed ID: 16965572
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Transfusion-related acute lung injury reports in the Netherlands: an observational study.
    van Stein D; Beckers EA; Sintnicolaas K; Porcelijn L; Danovic F; Wollersheim JA; Brand A; van Rhenen DJ
    Transfusion; 2010 Jan; 50(1):213-20. PubMed ID: 19694998
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Leukocyte antibodies and biologically active mediators in the pathogenesis of transfusion-related acute lung injury.
    Kopko PM
    Curr Hematol Rep; 2004 Nov; 3(6):456-61. PubMed ID: 15496281
    [TBL] [Abstract][Full Text] [Related]  

  • 29. White blood cell-reactive antibodies are undetectable in solvent/detergent plasma.
    Sachs UJ; Kauschat D; Bein G
    Transfusion; 2005 Oct; 45(10):1628-31. PubMed ID: 16181214
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Implementation of a strategy to prevent TRALI in a regional blood centre.
    Insunza A; Romon I; Gonzalez-Ponte ML; Hoyos A; Pastor JM; Iriondo A; Hermosa V
    Transfus Med; 2004 Apr; 14(2):157-64. PubMed ID: 15113380
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Transfusion-related acute lung injury: an unknown transfusion-related complication].
    Muller JY
    Ann Fr Anesth Reanim; 2004 Dec; 23(12):1131-2. PubMed ID: 15589351
    [No Abstract]   [Full Text] [Related]  

  • 32. Humoral immunomodulatory effect of influenza vaccine in potential blood donors: implications for transfusion safety.
    Delaney M; Warner P; Nelson K; Gleckler C; Price T; Madeleine M
    Transfus Med; 2011 Dec; 21(6):378-84. PubMed ID: 21883543
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Transfusion-related acute lung injury in the paediatric patient: Two case reports and a review of the literature.
    Church GD; Price C; Sanchez R; Looney MR
    Transfus Med; 2006 Oct; 16(5):343-8. PubMed ID: 16999757
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pulmonary pathology of rapidly fatal transfusion-related acute lung injury reveals minimal evidence of diffuse alveolar damage or alveolar granulocyte infiltration.
    Danielson C; Benjamin RJ; Mangano MM; Mills CJ; Waxman DA
    Transfusion; 2008 Nov; 48(11):2401-8. PubMed ID: 18673344
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Transfusion-related acute lung injury (TRALI) in graft by blood donor antibodies against host leukocytes.
    Goodwin J; Tinckam K; denHollander N; Haroon A; Keshavjee S; Cserti-Gazdewich CM
    J Heart Lung Transplant; 2010 Sep; 29(9):1067-70. PubMed ID: 20627626
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Predicted effect of selectively testing female donors for HLA antibodies to mitigate transfusion-related acute lung injury risk from apheresis platelets.
    Eder AF; Dy BA; O'Neill EM
    Transfusion; 2016 Jun; 56(6 Pt 2):1608-15. PubMed ID: 26830063
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Transfusion-related acute lung injury (TRALI): a case report and literature review.
    Donelan KJ; Anderson KA
    S D Med; 2011 Mar; 64(3):85-8. PubMed ID: 21473518
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Transfusion-related acute lung injury during plasma exchange: Suspecting the unsuspected.
    Askari S; Nollet K; Debol SM; Brunstein CG; Eastlund T
    J Clin Apher; 2002; 17(2):93-6. PubMed ID: 12210713
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Role of anti-human leucocyte antigen class II alloantibody and monocytes in development of transfusion-related acute lung injury.
    Nishimura M; Hashimoto S; Takanashi M; Okazaki H; Satake M; Nakajima K
    Transfus Med; 2007 Apr; 17(2):129-34. PubMed ID: 17430469
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Generation of inflammatory cytokines and chemokines from peripheral blood mononuclear cells by HLA Class II antibody-containing plasma unit that was associated with severe nonhemolytic transfusion reactions.
    Sakagawa H; Miyazaki T; Fujihara M; Sato S; Yamaguchi M; Fukai K; Morioka M; Kato T; Azuma H; Ikeda H
    Transfusion; 2007 Jan; 47(1):154-61. PubMed ID: 17207244
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.